These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 31561386)

  • 1. The Intestinal Barrier in Parkinson's Disease: Current State of Knowledge.
    van IJzendoorn SCD; Derkinderen P
    J Parkinsons Dis; 2019; 9(s2):S323-S329. PubMed ID: 31561386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can the gut be the missing piece in uncovering PD pathogenesis?
    Chapelet G; Leclair-Visonneau L; Clairembault T; Neunlist M; Derkinderen P
    Parkinsonism Relat Disord; 2019 Feb; 59():26-31. PubMed ID: 30448099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes of Colonic Bacterial Composition in Parkinson's Disease and Other Neurodegenerative Diseases.
    Gerhardt S; Mohajeri MH
    Nutrients; 2018 Jun; 10(6):. PubMed ID: 29857583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-gut-microbiota axis in Parkinson's disease.
    Mulak A; Bonaz B
    World J Gastroenterol; 2015 Oct; 21(37):10609-20. PubMed ID: 26457021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiome-Gut-Brain Axis and Toll-Like Receptors in Parkinson's Disease.
    Caputi V; Giron MC
    Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29882798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens.
    Awad WA; Hess C; Hess M
    Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probiotics, Prebiotics and Epithelial Tight Junctions: A Promising Approach to Modulate Intestinal Barrier Function.
    Rose EC; Odle J; Blikslager AT; Ziegler AL
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson's disease.
    Bhattarai Y; Si J; Pu M; Ross OA; McLean PJ; Till L; Moor W; Grover M; Kandimalla KK; Margolis KG; Farrugia G; Kashyap PC
    Gut Microbes; 2021 Jan; 13(1):1866974. PubMed ID: 33459114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysbiosis of gut microbiota and microbial metabolites in Parkinson's Disease.
    Sun MF; Shen YQ
    Ageing Res Rev; 2018 Aug; 45():53-61. PubMed ID: 29705121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review: The Role of Intestinal Dysbiosis in Parkinson's Disease.
    Huang Y; Liao J; Liu X; Zhong Y; Cai X; Long L
    Front Cell Infect Microbiol; 2021; 11():615075. PubMed ID: 33968794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases?
    Pellegrini C; Antonioli L; Colucci R; Blandizzi C; Fornai M
    Acta Neuropathol; 2018 Sep; 136(3):345-361. PubMed ID: 29797112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota and Intestinal Trans-Epithelial Permeability.
    Allam-Ndoul B; Castonguay-Paradis S; Veilleux A
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Gut and Parkinson's Disease: Hype or Hope?
    Scheperjans F; Derkinderen P; Borghammer P
    J Parkinsons Dis; 2018; 8(s1):S31-S39. PubMed ID: 30584161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Polysaccharide Isolated from Dictyophora indusiata Promotes Recovery from Antibiotic-Driven Intestinal Dysbiosis and Improves Gut Epithelial Barrier Function in a Mouse Model.
    Kanwal S; Joseph TP; Owusu L; Xiaomeng R; Meiqi L; Yi X
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30065236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial Barrier Function in Gut-Bone Signaling.
    Rios-Arce ND; Collins FL; Schepper JD; Steury MD; Raehtz S; Mallin H; Schoenherr DT; Parameswaran N; McCabe LR
    Adv Exp Med Biol; 2017; 1033():151-183. PubMed ID: 29101655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enteric Glia at the Crossroads between Intestinal Immune System and Epithelial Barrier: Implications for Parkinson Disease.
    Benvenuti L; D'Antongiovanni V; Pellegrini C; Antonioli L; Bernardini N; Blandizzi C; Fornai M
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal barrier integrity in patients with plaque psoriasis.
    Sikora M; Chrabąszcz M; Maciejewski C; Zaremba M; Waśkiel A; Olszewska M; Rudnicka L
    J Dermatol; 2018 Dec; 45(12):1468-1470. PubMed ID: 30222202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of the gut microbiota in Parkinson's disease].
    Verugina NI; Levin OS; Lyashenko EA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(10. Vyp. 2):86-91. PubMed ID: 34870920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intestinal barrier in disorders of the central nervous system.
    Pellegrini C; Fornai M; D'Antongiovanni V; Antonioli L; Bernardini N; Derkinderen P
    Lancet Gastroenterol Hepatol; 2023 Jan; 8(1):66-80. PubMed ID: 36334596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the intestinal mucosal barrier to the enteric neuromuscular compartment: an integrated overview on the morphological changes in Parkinson's disease.
    Pellegrini C; D'Antongiovanni V; Ippolito C; Segnani C; Antonioli L; Fornai M; Bernardini N
    Eur J Histochem; 2021 Nov; 65(s1):. PubMed ID: 34802221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.